Author name: Natalie Clark

Natalie Clark is a news writer for the Barnard Griffin Newsroom. She writes about health, sport, and tech, and her favorite story to write is about how the latest technology is making it easier for people to manage their health.

Avatar of Natalie Clark
54105426781 a3b8bf7052 k

Zoox co-founder on Tesla self-driving: ‘they don’t have technology that works’

Tech / By

Zoox co-founder and CTO Jesse Levinson doesn’t believe Tesla will launch a robotaxi ride-hailing service in California (or anywhere else) next year despite what Elon Musk recently claimed. The “fundamental issue is they don’t have technology that works,” Levinson said Wednesday at TechCrunch Disrupt 2024. “And by works, I want to differentiate between a driver […]

Zoox co-founder on Tesla self-driving: ‘they don’t have technology that works’ Read More »

108038916 1727270649111 IMG 5688

Starbucks CEO pledges to fundamentally change strategy as sales fall for third straight quarter

Business / By

Brian Niccol speaking on CNBC’s Squawk Box on Oct. 30th, 2018.  Anjali Sundaram | CNBC Starbucks is set to share more details about its fiscal fourth quarter after the bell on Wednesday. The coffee giant shared its preliminary quarterly results on Oct. 22, showing that its sales fell for the third consecutive quarter. Here’s what

Starbucks CEO pledges to fundamentally change strategy as sales fall for third straight quarter Read More »

108004561 1720707229456 gettyimages 2160946683 20090101240711 99 704452

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

Business / By

Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Picture Alliance | Picture Alliance | Getty Images All doses of Novo Nordisk‘s highly popular weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the U.S.

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says Read More »

108001062 1719945039163 gettyimages 2126120470 ZEPBOUND PATIENT SHORTAGES

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Business / By

Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines has largely recovered from widespread shortages in the U.S.  The reason for the disappointing sales, according to the company, is not an issue of demand or supply.  During an earnings call

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed Read More »

matt mullenweg

Matt Mullenweg talks about Automattic’s staffing issues and financials at TechCrunch Disrupt

Tech / By

WordPress co-creator and Automattic CEO Matt Mullenweg talked about his fight with WP Engine, Automattic’s staffing issues, and the company’s financials at TechCrunch Disrupt on Wednesday. Mullenweg repeated a lot of stuff from the past month about the trademark fight, WP Engine not contributing to the community, and misleading customers to believe it was associated with

Matt Mullenweg talks about Automattic’s staffing issues and financials at TechCrunch Disrupt Read More »

108047462 1728938825558 gettyimages 2172439479 20240919 lax ka 009

United Airlines raises spending requirements to earn frequent flyer status

Business / By

A United Airlines Boeing 757 departs from Los Angeles International Airport en route to New York on Sept. 19, 2024. Kevin Carter | Getty Images United Airlines customers will have to spend more to reach frequent flyer status next year, the latest move by the carrier to increase profits and give an exclusive feel to

United Airlines raises spending requirements to earn frequent flyer status Read More »

106947042 16324973582021 09 24t152814z 1898324953 rc2fwp98f0wz rtrmadp 0 usa economy

Pending home sales took an unexpected leap higher last month, but rates have climbed back up

Business / By

Signed contracts to buy existing homes in September jumped a surprising 7.4% compared with August, according to the National Association of Realtors. Analysts had been expecting about a 1% gain. These so-called pending sales were at the highest level since March and 2.6% higher than September of last year. Since pending sales are based on

Pending home sales took an unexpected leap higher last month, but rates have climbed back up Read More »

Barnard Griffin Newsroom promo

This Week in AI: A preview of Disrupt 2024’s stacked AI panels

Tech / By

Hiya, folks, welcome to TechCrunch’s regular AI newsletter. If you want this in your inbox every Wednesday, sign up here. This week, the TechCrunch crew (including yours truly) is at TC’s annual Disrupt conference in San Francisco. We’ve got a packed lineup of speakers from the AI industry, academia, and policy, so in lieu of my

This Week in AI: A preview of Disrupt 2024’s stacked AI panels Read More »

Start typing and press enter to search

Scroll to Top